0.01Open0.01Pre Close0 Volume30 Open Interest64.00Strike Price0.00Turnover269.54%IV18.93%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type-0.0048Delta0.0021Gamma7893.00Leverage Ratio-0.1148Theta0.0000Rho-37.71Eff Leverage0.0003Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet